Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of recombinant human growth hormone
(r-hGH) treatment in severe fibromyalgia subjects with growth axis dysfunction.